BMJ:老年人跌倒要命?增加乳制品摄入以提高钙和蛋白质可以显著降低跌倒和骨折风险!

2022-02-28 MedSci原创 MedSci原创

使用乳制品食品来提高钙和蛋白质的摄入量是一种容易实现的干预措施,可以减少老年护理居民通常发生的跌倒和骨折的风险。

长寿增加了人口中老年人的比例。伴随着慢性病发病率的增加,肌肉骨骼质量的下降,身体虚弱和骨质脆弱,都增加了老年人跌倒和骨折的风险。独立性的丧失增加了需要全职机构护理的人数,这是社区中大约30%的髋部骨折的来源。

广泛使用抗骨质疏松疗法不太可能减少骨折负担,因为对80岁以上人群的抗骨折疗效证据不足,不良事件经常发生。钙和蛋白质是强健骨骼的重要来源。为了评估缺乏维生素D但平均每天摄入600mg钙和<1g/kg体重蛋白质/天的住院老年人的抗骨折效果和安全性。来自澳大利亚墨尔本大学奥斯汀健康学院医学系开展了一项研究,结果发表在BMJ杂志上。

这是一项随机对照试验,纳入澳大利亚60家经认证的老年护理机构,主要是居住在户外的居民。参与者为7195名永久居民(4920名(68%)女性;平均年龄86.0(SD 8.2)岁)。干预设施按地点和组织分层,30家设施被随机提供给居民额外的牛奶、酸奶和奶酪,达到1142(353)毫克/天的钙和69(15)克/天的蛋白质(1.1克/公斤体重)的总摄入。30家对照机构维持其常规菜单,居民每天摄入700(247)毫克的钙和58(14)克/天的蛋白质(0.9克/公斤体重)。主要结果措施是评估骨折、跌倒和所有原因死亡发生率的群体差异。

结果对来自27个干预机构和29个对照机构的数据进行了分析。共观察到324例骨折(135例髋部骨折),4302例跌倒,以及1974例死亡。总的来说,干预措施使所有骨折的风险降低了33%(121vs203;HR=0.67,95%CI 0.48-0.93;P=0.02),髋部骨折的风险降低了46%(42vs93;HR=0.54,0.35-0.83;P=0.005),而跌倒的风险降低了11%(1879vs2423;HR=0.89,0.78=0.98;P=0.04)。

在基线和两年研究期间,两组组平均(SD)每天摄入的乳制品份数、能量、钙和蛋白质。

其中,髋部骨折和跌倒的风险降低分别在五个月(P=0.02)和三个月(P=0.004)时达到显著性。死亡率没有变化(900 vs 1074;HR=1.01,0.43-3.08)。

综上,通过使用乳制品食品来提高钙和蛋白质的摄入量是一种容易实现的干预措施,可以减少老年护理居民通常发生的跌倒和骨折的风险。

 

参考文献:

Effect of dietary sources of calcium and protein on hip fractures and falls in older adults in residential care: cluster randomised controlled trial. BMJ 2021; 375. doi: https://doi.org/10.1136/bmj.n2364

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1849375, encodeId=8f2518493e5df, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Mar 17 21:41:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765952, encodeId=83d41e659521f, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Oct 22 21:41:04 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297160, encodeId=ed57129e16030, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Feb 24 05:41:04 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390453, encodeId=229f139045363, content=<a href='/topic/show?id=22c6101695c9' target=_blank style='color:#2F92EE;'>#骨折风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101695, encryptionId=22c6101695c9, topicName=骨折风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Thu Feb 24 05:41:04 CST 2022, time=2022-02-24, status=1, ipAttribution=)]
    2022-03-17 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1849375, encodeId=8f2518493e5df, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Mar 17 21:41:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765952, encodeId=83d41e659521f, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Oct 22 21:41:04 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297160, encodeId=ed57129e16030, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Feb 24 05:41:04 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390453, encodeId=229f139045363, content=<a href='/topic/show?id=22c6101695c9' target=_blank style='color:#2F92EE;'>#骨折风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101695, encryptionId=22c6101695c9, topicName=骨折风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Thu Feb 24 05:41:04 CST 2022, time=2022-02-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1849375, encodeId=8f2518493e5df, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Mar 17 21:41:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765952, encodeId=83d41e659521f, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Oct 22 21:41:04 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297160, encodeId=ed57129e16030, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Feb 24 05:41:04 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390453, encodeId=229f139045363, content=<a href='/topic/show?id=22c6101695c9' target=_blank style='color:#2F92EE;'>#骨折风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101695, encryptionId=22c6101695c9, topicName=骨折风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Thu Feb 24 05:41:04 CST 2022, time=2022-02-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1849375, encodeId=8f2518493e5df, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Mar 17 21:41:04 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765952, encodeId=83d41e659521f, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Oct 22 21:41:04 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297160, encodeId=ed57129e16030, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Feb 24 05:41:04 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390453, encodeId=229f139045363, content=<a href='/topic/show?id=22c6101695c9' target=_blank style='color:#2F92EE;'>#骨折风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101695, encryptionId=22c6101695c9, topicName=骨折风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Thu Feb 24 05:41:04 CST 2022, time=2022-02-24, status=1, ipAttribution=)]

相关资讯

JBMR:HIV感染与髋部骨折风险密切相关,与年龄,性别和并发症无关

大量研究发现,与普通人群相比,艾滋病毒感染者的骨密度更低,骨质流失率更高

J INTERN MED:髋部骨折可改变危险因素的性别差异

中国成年人髋部骨折的年龄和性别特异性发病率与西方人群相当。五个潜在的可改变因素占男性髋部骨折的一半,占女性髋部骨折的四分之一。

Age & Ageing:注意啦!老年人髋部骨折后抑郁风险明显增加!

髋部骨折后的老年人有独特的抑郁症状亚型,并提供了独特临床表型的确认证据

Aging Clin Exp Res:肌肽可作为监测接受康复和营养治疗的髋部骨折患者肌肉减少症发生的生物标志物

髋部骨折是最常见的与老年人残疾有关的骨质疏松性骨折,需要手术和随后的康复治疗。目前,肌肉减少症被认为是髋部骨折患者结局恶化的预测因素,最近有学者提出肌肽可作为潜在的生物标志物,为此研究人员进行了探究,

JAMA Intern Med:40年数据提醒,预防这种“杀手级骨折”,不妨戒烟酒

髋部骨折由于死亡率高,也被称为“人生最后一次骨折”。髋部骨折常见于老年人,患者往往面临手术风险,骨折后完全康复率低,受伤卧床也会带来多种并发症。

J INTERN MED:髋部骨折患者停用抗骨质疏松药物后骨折风险增加

停用狄诺塞麦会导致骨质疏松性骨折的风险增加,尤其是椎体骨折,增加的风险往往会在停药后一年内显现出来。

拓展阅读

Hip Pelvis:髋部骨折患者的骨健康评估和继发性脆性骨折

本研究旨在探讨骨健康评估在老年髋部骨折患者中的应用,并确定未来脆性骨折发展的危险因素。

髋部骨折手术使用多种麻醉药物可能增加术后谵妄?

新近的一项研究显示,术中使用多种麻醉药物、全麻都可能增加术后谵妄发生率。另外,术前低蛋白也是谵妄发生风险因素。

Hip Pelvis:新冠肺炎疫情对髋部骨折患者康复的影响

大流行疫情对住院护理医院的老年髋部骨折患者术后活动的恢复有不利影响,在完全限制家属进入以防止感染的情况下。

Anesthesia & Analgesia:老年人群衰弱与髋部骨折术后临床结局和生活质量的 关系:一项回顾性队列研究

衰弱与老年患者髋关节骨折术后 12 个月的术后不良结局、更高的死亡率和低生活质量相关。

JBJS Open Access:髋部骨折后血栓预防药物的有效性研究

多项研究比较了髋部骨折术后不同的药物血栓预防药物,包括阿司匹林、低分子肝素、直接口服抗凝剂和华法林,旨在确定血栓预防在减少手术治疗髋部骨折患者静脉血栓栓塞(VTE)方面的比较效果。

BMC Musculoskelet Disord:老年髋部骨折患者延迟出院风险预测模型

老年髋部骨折患者由于身体状况不佳,往往需要长期住院治疗,经济负担增加。目前对于髋部骨折延迟出院的预测模型很少。本研究旨在建立髋部骨折延迟出院的最佳模型,以支持临床决策。